Insider trades
Brian C. Stephenson, CFO of Faeth Therapeutics FTH, has filed 16 purchases and 17 sales on the open market. Over the past 12 months that comes to a net purchase of $807.2K. The latest trade was on 06/26.
Brian C. Stephenson
CFO
- Company
- Faeth Therapeutics FTH
- First filing
- 23/01/06
- Trades
- 101 trades
- Buys / sales
- 16 / 17
- 12-month net buying
- $807.2K
- Last trade
- 06/26
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
FTH | Open-market buy | 06/24–06/26 | 06/26 | 15,641 sh8 trades | $25.65avg. | $401,268.52 | +89.8% |
FTH | Open-market buy | 06/22–06/23 | 06/24 | 17,413 sh8 trades | $23.31avg. | $405,920.62 | No record |
BBIO | Open-market sale10b5-1 plan | 25/02/25 | 25/02/27 | 8,500 sh2 trades | $33.19avg. | $282,130 | −7.7% |
BridgeBio PharmaBBIO | Open-market sale10b5-1 plan | 25/02/19 | 25/02/19 | 4,148 sh | $36.16 | $149,991.68 | −3.9% |
BridgeBio PharmaBBIO | Open-market sale10b5-1 plan | 25/01/28 | 25/01/30 | 68,000 sh | $36.29 | $2,467,720 | −42.0% |
BridgeBio PharmaBBIO | Open-market sale10b5-1 plan | 24/11/19 | 24/11/20 | 4,156 sh | $22.41 | $93,135.96 | −4.2% |
BBIO | Open-market sale10b5-1 plan | 24/08/19 | 24/08/20 | 4,155 sh2 trades | $24.69avg. | $102,596.97 | −4.7% |
BridgeBio PharmaBBIO | Open-market sale10b5-1 plan | 23/11/17 | 23/11/20 | 22,685 sh | $29.10 | $660,133.5 | −38.2% |
BridgeBio PharmaBBIO | Open-market sale10b5-1 plan | 23/08/17 | 23/08/18 | 22,683 sh | $28.59 | $648,506.97 | −38.2% |
BridgeBio PharmaBBIO | Open-market sale10b5-1 plan | 23/05/17 | 23/05/18 | 24,424 sh | $14.01 | $342,180.24 | −40.1% |
BridgeBio PharmaBBIO | Open-market sale10b5-1 plan | 23/05/03 | 23/05/05 | 64,929 sh | $14.18 | $920,693.22 | −64.1% |
BridgeBio PharmaBBIO | Open-market sale10b5-1 plan | 23/04/05 | 23/04/07 | 55,500 sh | $15.45 | $857,475 | −35.4% |
BridgeBio PharmaBBIO | Open-market sale | 23/03/03 | 23/03/03 | 62,692 sh | $10.96 | $687,104.32 | −28.6% |
BBIO | Open-market sale | 23/02/17 | 23/02/21 | 17,717 sh2 trades | $12.70avg. | $225,001.55 | −7.5% |
BridgeBio PharmaBBIO | Open-market sale | 23/02/03 | 23/02/06 | 61,040 sh | $11.01 | $672,050.4 | −21.8% |
BridgeBio PharmaBBIO | Open-market sale | 23/01/05 | 23/01/06 | 61,040 sh | $7.67 | $468,176.8 | −17.9% |
